Nirsevimab sharply cuts RSV hospitalizations in U.S. infants during the 2024–2025 season – News-Medical

  1. Nirsevimab sharply cuts RSV hospitalizations in U.S. infants during the 2024–2025 season  News-Medical
  2. ‘So scary when children are that young’: Mother and doctors call for more RSV awareness and protection  CTV News
  3. RSV around the World: The Good (and Bad) News  Scientific American
  4. A Turning Point in Infant Health—How 2023 Changed the Fight Against RSV  Scientific American
  5. From Tragedy to Eureka—The Long Road to RSV Drugs  Scientific American

Leave a Comment

Your email address will not be published. Required fields are marked *